Skip to content
1887

Journal of General Virology header logo Journal of General Virology

Volume 90, Issue 4

Acute-phase CD4 T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian–human immunodeficiency virus strain 89.6p-infected macaques No Access

Abstract

Human immunodeficiency virus (HIV) infection in humans and simian immunodeficiency virus (SIV) infection in macaques are accompanied by a combined early loss of CCR5 (CD195)-expressing CD4 memory T cells, loss of T-helper function and T-cell hyperactivation, which have all been associated with development of high virus load and disease progression. Here, a cohort of vaccinated simian–human immunodeficiency virus strain 89.6p (SHIV)-infected rhesus macaques, where preferential depletion of these memory T-cell subsets does not take place and CD4 T cells are relatively well maintained, was used to study the role of hyperactivation as an independent factor in the establishment of set-point virus load. In the acute phase of the infection, a transient loss of CD4 T cells, as well as strong increases in expression of proliferation and activation markers on CD4 and CD8 T cells, together with CD152 expression on CD4 T cells, were observed. Peak expression levels of these markers on CD4 T cells, but not on CD8 T cells, were correlated with high virus replication in the chronic phase of the infection. In addition, the peak expression level of these markers was correlated inversely with acute-phase, but not chronic-phase, HIV/SIV-specific gamma interferon responses. These data highlight a central role for an acute but transient CD4 decrease, as well as CD4 T-cell activation, as independent factors for prediction of set-point levels of virus replication.

  • Received:
  • Accepted:
  • Published Online:
SGM
Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.2008.006148-0
2009-04-01
2025-11-13

Metrics

Loading full text...

Full text loading...

References

  1. Amara R. R., Villinger F., Altman J. D., Lydy S. L., O'Neil S. P., Staprans S. I., Montefiori D. C., Xu Y., Herndon J. G. other authors 2001; Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine. Science 292:69–74 [CrossRef]
     [Google Scholar]
  2. Andersson J., Boasso A., Nilsson J., Zhang R., Shire N. J., Lindback S., Shearer G. M., Chougnet C. A. 2005; The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients. J Immunol 174:3143–3147 [CrossRef]
     [Google Scholar]
  3. Barouch D. H., Santra S., Schmitz J. E., Kuroda M. J., Fu T. M., Wagner W., Bilska M., Craiu A., Zheng X. X. other authors 2000; Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290:486–492 [CrossRef]
     [Google Scholar]
  4. Brenchley J. M., Schacker T. W., Ruff L. E., Price D. A., Taylor J. H., Beilman G. J., Nguyen P. L., Khoruts A., Larson M. other authors 2004; CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J Exp Med 200:749–759 [CrossRef]
     [Google Scholar]
  5. Carbone J., Gil J., Benito J. M., Navarro J., Muñóz-Fernández A., Bartolomé J., Zabay J. M., López F., Fernández-Cruz E. 2000; Increased levels of activated subsets of CD4 T cells add to the prognostic value of low CD4 T cell counts in a cohort of HIV-infected drug users. AIDS 14:2823–2829 [CrossRef]
     [Google Scholar]
  6. Cefai D., Ferrer M., Serpente N., Idziorek T., Dautry-Varsat A., Debre P., Bismuth G. 1992; Internalization of HIV glycoprotein gp120 is associated with down-modulation of membrane CD4 and p56lck together with impairment of T cell activation. J Immunol 149:285–294
     [Google Scholar]
  7. Clerici M., Shearer G. M. 1993; A Th1→Th2 switch is a critical step in the etiology of HIV infection. Immunol Today 14:107–111 [CrossRef]
     [Google Scholar]
  8. Deeks S. G., Kitchen C. M., Liu L., Guo H., Gascon R., Narvaez A. B., Hunt P., Martin J. N., Kahn J. O. other authors 2004; Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 104:942–947 [CrossRef]
     [Google Scholar]
  9. Doria-Rose N. A., Ohlen C., Polacino P., Pierce C. C., Hensel M. T., Kuller L., Mulvania T., Anderson D., Greenberg P. D. other authors 2003; Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge. J Virol 77:11563–11577 [CrossRef]
     [Google Scholar]
  10. Epple H. J., Loddenkemper C., Kunkel D., Troger H., Maul J., Moos V., Berg E., Ullrich R., Schulzke J. D. other authors 2006; Mucosal but not peripheral FOXP3+ regulatory T cells are highly increased in untreated HIV infection and normalize after suppressive HAART. Blood 108:3072–3078 [CrossRef]
     [Google Scholar]
  11. Estes J. D., Li Q., Reynolds M. R., Wietgrefe S., Duan L., Schacker T., Picker L. J., Watkins D. I., Lifson J. D. other authors 2006; Premature induction of an immunosuppressive regulatory T cell response during acute simian immunodeficiency virus infection. J Infect Dis 193:703–712 [CrossRef]
     [Google Scholar]
  12. Fauci A. S. 1988; The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617–622 [CrossRef]
     [Google Scholar]
  13. Froebel K. S., Raab G. M., D'Alessandro C., Armitage M. P., MacKenzie K. M., Struthers M., Whitelaw J. M., Yang S. 2000; A single measurement of CD38CD8 cells in HIV+, long-term surviving injecting drug users distinguishes those who will progress to AIDS from those who will remain stable. Clin Exp Immunol 122:72–78 [CrossRef]
     [Google Scholar]
  14. Gougeon M. L., Garcia S., Heeney J., Tschopp R., Lecoeur H., Guetard D., Rame V., Dauguet C., Montagnier L. 1993; Programmed cell death in AIDS-related HIV and SIV infections. AIDS Res Hum Retroviruses 9:553–563 [CrossRef]
     [Google Scholar]
  15. Gougeon M. L., Lecoeur H., Boudet F., Ledru E., Marzabal S., Boullier S., Roue R., Nagata S., Heeney J. 1997; Lack of chronic immune activation in HIV-infected chimpanzees correlates with the resistance of T cells to Fas/Apo-1 (CD95)-induced apoptosis and preservation of a T helper 1 phenotype. J Immunol 158:2964–2976
     [Google Scholar]
  16. Gruters R. A., Terpstra F. G., De Goede R. E., Mulder J. W., De Wolf F., Schellekens P. T., Van Lier R. A., Tersmette M., Miedema F. 1991; Immunological and virological markers in individuals progressing from seroconversion to AIDS. AIDS 5:837–844 [CrossRef]
     [Google Scholar]
  17. Hazenberg M. D., Otto S. A., Cohen Stuart J. W., Verschuren M. C., Borleffs J. C., Boucher C. A., Coutinho R. A., Lange J. M., Rinke de Wit T. F. other authors 2000; Increased cell division but not thymic dysfunction rapidly affects the T-cell receptor excision circle content of the naive T cell population in HIV-1 infection. Nat Med 6:1036–1042 [CrossRef]
     [Google Scholar]
  18. Hazenberg M. D., Otto S. A., van Benthem B. H., Roos M. T., Coutinho R. A., Lange J. M., Hamann D., Prins M., Miedema F. 2003; Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS 17:1881–1888 [CrossRef]
     [Google Scholar]
  19. Horton H., Vogel T. U., Carter D. K., Vielhuber K., Fuller D. H., Shipley T., Fuller J. T., Kunstman K. J., Sutter G. other authors 2002; Immunization of rhesus macaques with a DNA prime/modified vaccinia virus Ankara boost regimen induces broad simian immunodeficiency virus (SIV)-specific T-cell responses and reduces initial viral replication but does not prevent disease progression following challenge with pathogenic SIVmac239. J Virol 76:7187–7202 [CrossRef]
     [Google Scholar]
  20. Hryniewicz A., Boasso A., Edghill-Smith Y., Vaccari M., Fuchs D., Venzon D., Nacsa J., Betts M. R., Tsai W. P. other authors 2006; CTLA-4 blockade decreases TGF- β , IDO, and viral RNA expression in tissues of SIVmac251-infected macaques. Blood 108:3834–3842 [CrossRef]
     [Google Scholar]
  21. Karlsson I., Malleret B., Brochard P., Delache B., Calvo J., Le Grand R., Vaslin B. 2007; FoxP3+ CD25+ CD8+ T-cell induction during primary simian immunodeficiency virus infection in cynomolgus macaques correlates with low CD4+ T-cell activation and high viral load. J Virol 81:13444–13455 [CrossRef]
     [Google Scholar]
  22. Kinter A. L., Hennessey M., Bell A., Kern S., Lin Y., Daucher M., Planta M., McGlaughlin M., Jackson R. other authors 2004; CD25+CD4+ regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4+ and CD8+ HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J Exp Med 200:331–343 [CrossRef]
     [Google Scholar]
  23. Koopman G., Niphuis H., Newman W., Kishimoto T. K., Maino V. C., Heeney J. L. 2001; Decreased expression of IL-2 in central and effector CD4 memory cells during progression to AIDS in rhesus macaques. AIDS 15:2359–2369 [CrossRef]
     [Google Scholar]
  24. Koopman G., Mortier D., Hofman S., Niphuis H., Fagrouch Z., Norley S., Sutter G., Liljestrom P., Heeney J. L. 2004; Vaccine protection from CD4+ T-cell loss caused by simian immunodeficiency virus (SIV) mac251 is afforded by sequential immunization with three unrelated vaccine vectors encoding multiple SIV antigens. J Gen Virol 85:2915–2924 [CrossRef]
     [Google Scholar]
  25. Koopman G., Mortier D., Hofman S., Mathy N., Koutsoukos M., Ertl P., Overend P., van Wely C., Thomson L. J. other authors 2008; Immune-response profiles induced by human immunodeficiency virus type 1 vaccine DNA, protein, or mixed-modality immunization: increased protection from pathogenic simian–human immunodeficiency virus viraemia with protein/DNA combination. J Gen Virol 89:540–553 [CrossRef]
     [Google Scholar]
  26. Lane H. C., Depper J. M., Greene W. C., Whalen G., Waldmann T. A., Fauci A. S. 1985; Qualitative analysis of immune function in patients with the acquired immunodeficiency syndrome. Evidence for a selective defect in soluble antigen recognition. N Engl J Med 313:79–84 [CrossRef]
     [Google Scholar]
  27. Leng Q., Bentwich Z., Magen E., Kalinkovich A., Borkow G. 2002; CTLA-4 upregulation during HIV infection: association with anergy and possible target for therapeutic intervention. AIDS 16:519–529 [CrossRef]
     [Google Scholar]
  28. Li Q., Duan L., Estes J. D., Ma Z. M., Rourke T., Wang Y., Reilly C., Carlis J., Miller C. J. other authors 2005; Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 434:1148–1152
     [Google Scholar]
  29. Lifson A. R., Rutherford G. W., Jaffe H. W. 1988; The natural history of human immunodeficiency virus infection. J Infect Dis 158:1360–1367 [CrossRef]
     [Google Scholar]
  30. Marcondes M. C., Penedo M. C., Lanigan C., Hall D., Watry D. D., Zandonatti M., Fox H. S. 2006; Simian immunodeficiency virus-induced CD4+ T cell deficits in cytokine secretion profile are dependent on monkey origin. Viral Immunol 19:679–689 [CrossRef]
     [Google Scholar]
  31. Mattapallil J. J., Letvin N. L., Roederer M. 2004; T-cell dynamics during acute SIV infection. AIDS 18:13–23 [CrossRef]
     [Google Scholar]
  32. Mattapallil J. J., Douek D. C., Hill B., Nishimura Y., Martin M., Roederer M. 2005; Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 434:1093–1097 [CrossRef]
     [Google Scholar]
  33. McKay P. F., Barouch D. H., Schmitz J. E., Veazey R. S., Gorgone D. A., Lifton M. A., Williams K. C., Letvin N. L. 2003; Global dysfunction of CD4 T-lymphocyte cytokine expression in simian–human immunodeficiency virus/SIV-infected monkeys is prevented by vaccination. J Virol 77:4695–4702 [CrossRef]
     [Google Scholar]
  34. Meyaard L., Otto S. A., Jonker R. R., Mynster M. J., Keet R. P. M., Miedema F. 1992; Programmed death of T cells in HIV-1 infection. Science 257:217–219 [CrossRef]
     [Google Scholar]
  35. Meyaard L., Hovenkamp E., Keet I. P., Hooibrink B., de Jong I. H., Otto S. A., Miedema F. 1996; Single cell analysis of IL-4 and IFN- γ production by T cells from HIV-infected individuals: decreased IFN- γ in the presence of preserved IL-4 production. J Immunol 157:2712–2718
     [Google Scholar]
  36. Miedema F., Petit A. J., Terpstra F. G., Schattenkerk J. K., de Wolf F., Al B. J., Roos M., Lange J. M., Danner S. A. other authors 1988; Immunological abnormalities in human immunodeficiency virus (HIV)-infected asymptomatic homosexual men. HIV affects the immune system before CD4+ T helper cell depletion occurs. J Clin Invest 82:1908–1914 [CrossRef]
     [Google Scholar]
  37. Montes M., Lewis D. E., Sanchez C., de Castilla D. L., Graviss E. A., Seas C., Gotuzzo E., White A. C. Jr 2006; Foxp3+ regulatory T cells in antiretroviral-naive HIV patients. AIDS 20:1669–1671 [CrossRef]
     [Google Scholar]
  38. Mooij P., Nieuwenhuis I. G., Knoop C. J., Doms R. W., Bogers W. M., Ten Haaft P. J., Niphuis H., Koornstra W., Bieler K. other authors 2004; Qualitative T-helper responses to multiple viral antigens correlate with vaccine-induced immunity to simian/human immunodeficiency virus infection. J Virol 78:3333–3342 [CrossRef]
     [Google Scholar]
  39. Nilsson J., Boasso A., Velilla P. A., Zhang R., Vaccari M., Franchini G., Shearer G. M., Andersson J., Chougnet C. 2006; HIV-1-driven regulatory T-cell accumulation in lymphoid tissues is associated with disease progression in HIV/AIDS. Blood 108:3808–3817 [CrossRef]
     [Google Scholar]
  40. Nishimura Y., Igarashi T., Donau O. K., Buckler-White A., Buckler C., Lafont B. A., Goeken R. M., Goldstein S., Hirsch V. M. other authors 2004; Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc Natl Acad Sci U S A 101:12324–12329 [CrossRef]
     [Google Scholar]
  41. Reimann K. A., Parker R. A., Seaman M. S., Beaudry K., Beddall M., Peterson L., Williams K. C., Veazey R. S., Montefiori D. C. other authors 2005; Pathogenicity of simian–human immunodeficiency virus SHIV-89.6P and SIVmac is attenuated in cynomolgus macaques and associated with early T-lymphocyte responses. J Virol 79:8878–8885 [CrossRef]
     [Google Scholar]
  42. Ribeiro R. M., Mohri H., Ho D. D., Perelson A. S. 2002; In vivo dynamics of T cell activation, proliferation, and death in HIV-1 infection: why are CD4+ but not CD8+ T cells depleted?. Proc Natl Acad Sci U S A 99:15572–15577 [CrossRef]
     [Google Scholar]
  43. Schindler M., Münch J., Kutsch O., Li H., Santiago M. L., Bibollet-Ruche F., Müller-Trutwin M. C., Novembre F. J., Peeters M. other authors 2006; Nef-mediated suppression of T cell activation was lost in a lentiviral lineage that gave rise to HIV-1. Cell 125:1055–1067 [CrossRef]
     [Google Scholar]
  44. Shearer G. M., Clerici M. 1991; Early T-helper cell defects in HIV infection. AIDS 5:245–253
     [Google Scholar]
  45. Shiver J. W., Fu T. M., Chen L., Casimiro D. R., Davies M. E., Evans R. K., Zhang Z. Q., Simon A. J., Trigona W. L. other authors 2002; Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415:331–335 [CrossRef]
     [Google Scholar]
  46. Silvestri G., Sodora D. L., Koup R. A., Paiardini M., O'Neil S. P., McClure H. M., Staprans S. I., Feinberg M. B. 2003; Nonpathogenic SIV infection of sooty mangabeys is characterized by limited bystander immunopathology despite chronic high-level viremia. Immunity 18:441–452 [CrossRef]
     [Google Scholar]
  47. Silvestri G., Fedanov A., Germon S., Kozyr N., Kaiser W. J., Garber D. A., McClure H., Feinberg M. B., Staprans S. I. 2005; Divergent host responses during primary simian immunodeficiency virus SIVsm infection of natural sooty mangabey and nonnatural rhesus macaque hosts. J Virol 79:4043–4054 [CrossRef]
     [Google Scholar]
  48. Sopper S., Sauer U., Müller J. G., Stahl-Hennig C., ter Meulen V. 2000; Early activation and proliferation of T cells in simian immunodeficiency virus-infected rhesus monkeys. AIDS Res Hum Retroviruses 16:689–697 [CrossRef]
     [Google Scholar]
  49. Sousa A. E., Carneiro J., Meier-Schellersheim M., Grossman Z., Victorino R. M. 2002; CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J Immunol 169:3400–3406 [CrossRef]
     [Google Scholar]
  50. Sumpter B., Dunham R., Gordon S., Engram J., Hennessy M., Kinter A., Paiardini M., Cervasi B., Klatt N. other authors 2007; Correlates of preserved CD4+ T cell homeostasis during natural, nonpathogenic simian immunodeficiency virus infection of sooty mangabeys: implications for AIDS pathogenesis. J Immunol 178:1680–1691 [CrossRef]
     [Google Scholar]
  51. Sun Y., Permar S. R., Buzby A. P., Letvin N. L. 2007; Memory CD4+ T-lymphocyte loss and dysfunction during primary simian immunodeficiency virus infection. J Virol 81:8009–8015 [CrossRef]
     [Google Scholar]
  52. Takeda A., Igarashi H., Nakamura H., Kano M., Iida A., Hirata T., Hasegawa M., Nagai Y., Matano T. 2003; Protective efficacy of an AIDS vaccine, a single DNA priming followed by a single booster with a recombinant replication-defective Sendai virus vector, in a macaque AIDS model. J Virol 77:9710–9715 [CrossRef]
     [Google Scholar]
  53. Ten Haaft P., Verstrepen B., Uberla K., Rosenwirth B., Heeney J. 1998; A pathogenic threshold of virus load defined in simian immunodeficiency virus- or simian-human immunodeficiency virus-infected macaques. J Virol 72:10281–10285
     [Google Scholar]
  54. Tsunemi S., Iwasaki T., Imado T., Higasa S., Kakishita E., Shirasaka T., Sano H. 2005; Relationship of CD4+CD25+ regulatory T cells to immune status in HIV-infected patients. AIDS 19:879–886 [CrossRef]
     [Google Scholar]
  55. Veazey R. S., DeMaria M., Chalifoux L. V., Shvetz D. E., Pauley D. R., Knight H. L., Rosenzweig M., Johnson R. P., Desrosiers R. C. other authors 1998; Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science 280:427–431 [CrossRef]
     [Google Scholar]
  56. Veazey R. S., Mansfield K. G., Tham I. C., Carville A. C., Shvetz D. E., Forand A. E., Lackner A. A. 2000; Dynamics of CCR5 expression by CD4+ T cells in lymphoid tissues during simian immunodeficiency virus infection. J Virol 74:11001–11007 [CrossRef]
     [Google Scholar]
  57. Voss G., Manson K., Montefiori D., Watkins D. I., Heeney J., Wyand M., Cohen J., Bruck C. 2003; Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine. J Virol 77:1049–1058 [CrossRef]
     [Google Scholar]
  58. Westendorp M. O., Frank R., Ochsenbauer C., Stricker K., Dhein J., Walczak H., Debatin K. M., Krammer P. H. 1995; Sensitization of T cells to CD95-mediated apoptosis by HIV-1 Tat and gp120. Nature 375:497–500 [CrossRef]
     [Google Scholar]
  59. Zaunders J. J., Munier M. L., Kaufmann D. E., Ip S., Grey P., Smith D., Ramacciotti T., Quan D., Finlayson R. other authors 2005; Early proliferation of CCR5+ CD38+++ antigen-specific CD4+ Th1 effector cells during primary HIV-1 infection. Blood 106:1660–1667 [CrossRef]
     [Google Scholar]
  60. Zaunders J. J., Ip S., Munier M. L., Kaufmann D. E., Suzuki K., Brereton C., Sasson S. C., Seddiki N., Koelsch K. other authors 2006; Infection of CD127+ (interleukin-7 receptor+) CD4+ cells and overexpression of CTLA-4 are linked to loss of antigen-specific CD4 T cells during primary human immunodeficiency virus type 1 infection. J Virol 80:10162–10172 [CrossRef]
     [Google Scholar]
/content/journal/jgv/10.1099/vir.2008.006148-0
Loading
Acute-phase CD4+ T-cell proliferation and CD152 upregulation predict set-point virus replication in vaccinated simian–human immunodeficiency virus strain 89.6p-infected macaques
J. Gen. Virol. 90, 915 (2009); https://doi.org/10.1099/vir.2008.006148-0
/content/journal/jgv/10.1099/vir.2008.006148-0
/content/journal/jgv/10.1099/vir.2008.006148-0
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An error occurred
Approval was partially successful, following selected items could not be processed due to error